CDKL5 Gene Early Infantile Epileptic Encephalopathy Type 2 NGS Genetic DNA Test
Introduction
The CDKL5 Gene Early Infantile Epileptic Encephalopathy Type 2 NGS Genetic DNA Test is an advanced diagnostic tool designed to identify mutations in the CDKL5 gene, which are responsible for severe neurological disorders, particularly in infants. This test employs Next Generation Sequencing (NGS) technology to provide accurate and comprehensive results, enabling healthcare providers to make informed decisions regarding patient care.
What the Test Measures
This genetic test specifically measures and detects mutations in the CDKL5 gene. These mutations are linked to Early Infantile Epileptic Encephalopathy (EIEE) type 2, a condition characterized by early-onset seizures and developmental delays.
Who Should Consider This Test?
The CDKL5 Gene test is recommended for infants and children exhibiting symptoms such as:
- Severe seizures starting in the first few months of life
- Developmental delays or regression
- Abnormal movements or behaviors
Parents with a family history of neurological disorders may also consider this test as a proactive measure.
Benefits of Taking the Test
Understanding the genetic basis of a child’s neurological condition can offer several benefits:
- Early diagnosis and intervention strategies
- Informed family planning and genetic counseling
- Access to targeted therapies and support services
This test empowers families with knowledge, allowing them to make informed decisions about their child’s health and future.
Understanding Your Results
Results from the CDKL5 Gene test will provide insights into whether a mutation is present. Healthcare providers will guide you through interpreting the results, discussing potential implications for treatment and management.
Pricing Information
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| CDKL5 Gene Early Infantile Epileptic Encephalopathy Type 2 NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
How to Book the Test
To book the CDKL5 Gene Early Infantile Epileptic Encephalopathy Type 2 NGS Genetic DNA Test, please contact us at +2348077798758 for more information or to schedule an appointment. Our team is ready to assist you in navigating the testing process.
Additional Information
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-Test Instructions: It is essential to have a clinical history of the patient and a genetic counseling session to draw a pedigree chart of family members affected with CDKL5 Gene Early Infantile Epileptic Encephalopathy Type 2.
For any inquiries or to book your test, please call or WhatsApp us at +2348077798758.
